Phase 1 Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-VMD2-hMERTK) Gene Vector to Patients with Retinal Disease due to MERTK Mutations
2020-07-04
عنوان الدراسة
Phase 1 Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-VMD2-hMERTK) Gene Vector to Patients with Retinal Disease due to MERTK Mutations
داعم الدراسة
PSCDR
دواء الدراسة
rAAV2-VMD2-hMERTK
رقم بروتوكول الدراسة
rAAV2-VMD2-hMERTK
حالة الدراسة
Completed
موقع الدراسة
King Faisal Specialist Hospital and Research Center (Riyadh), King Khaled Eye Specialist Hospital (Riyadh)
مرحلة الدراسة
1
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。